R, B., FP, M., F, G., M, T., R, S., A, L., . . . F, P. (2026). Strengths and pitfalls of NNT and NNH in early breast cancer escalation trials. Breast (Edinburgh, Scotland), 88, 104820. https://doi.org/10.1016/j.breast.2026.104820
Chicago Style (17th ed.) CitationR, Buonaiuto, et al. "Strengths and Pitfalls of NNT and NNH in Early Breast Cancer Escalation Trials." Breast (Edinburgh, Scotland) 88 (2026): 104820. https://doi.org/10.1016/j.breast.2026.104820.
MLA (9th ed.) CitationR, Buonaiuto, et al. "Strengths and Pitfalls of NNT and NNH in Early Breast Cancer Escalation Trials." Breast (Edinburgh, Scotland), vol. 88, 2026, p. 104820, https://doi.org/10.1016/j.breast.2026.104820.
Warning: These citations may not always be 100% accurate.